Qandli diabet - bu jiddiy va o'limga olib kelishi mumkin bo'lgan kasallik.
Jahon sog'liqni saqlash tashkiloti (JSST) ma'lumotlariga ko'ra, diabet har yili 1,5 milliondan ortiq odamning o'limiga to'g'ridan-to'g'ri sabab bo'lib, yurak-qon tomir kasalliklari, insult va buyrak yetishmovchiligi kabi boshqa kasalliklarning asosiy xavf omilidir.
2019-yilda diabet butun dunyo bo'ylab o'limning to'qqizinchi asosiy sababi bo'lib, taxminan 1,5 million kishi ushbu kasallikdan o'lgan.
Biroq, diabet bilan bog'liq o'limlar soni ancha ko'p bo'lishi mumkin, chunki u ko'pincha o'lim sababi sifatida kam ko'rsatiladi.
Qandli diabetning to'g'ridan-to'g'ri ta'siridan tashqari, kasallik hayot uchun xavfli bo'lishi mumkin bo'lgan turli xil asoratlarga olib kelishi mumkin.
Ushbu asoratlarga yurak kasalligi, insult, buyrak yetishmovchiligi, asablarning shikastlanishi va ko'rish qobiliyatini yo'qotish kiradi.
Shuningdek, diabet bilan og'rigan odamlar infektsiyalarga chalinish xavfi yuqori bo'lib, yaralar sekinroq shifo topadi, bu esa og'ir asoratlarga va hatto o'limga olib kelishi mumkin.
Shuni ta'kidlash kerakki, to'g'ri parvarishlash va davolash bilan diabet bilan bog'liq xavf-xatarlarni sezilarli darajada kamaytirish mumkin.
Bunga qon shakarini yaxshi nazorat qilish, muntazam tekshiruvlar va yuqori qon bosimi va xolesterin darajasi kabi boshqa xavf omillarini boshqarish kiradi.
Qandli diabetni samarali boshqarish orqali odamlar asoratlarga duchor bo'lish xavfini kamaytirishlari va umumiy sog'liqni saqlashni yaxshilashlari mumkin.
Lin YP, Lu TH: Trends in death rate from diabetes according to multiple-cause-of-death differed from that according to underlying-cause-of-death in Taiwan but not in the United States, 1987-2007. J Clin Epidemiol. 2012, 65 (5): 572-6.
Zhu M, Li J, Li Z, Luo W, Dai D, Weaver SR, Stauber C, Luo R, Fu H: Mortality rates and the causes of death related to diabetes mellitus in Shanghai Songjiang District: an 11-year retrospective analysis of death certificates. BMC Endocr Disord. 2015, 15 (): 45.
McFarland KF, Hemaya E: Neonatal mortality in infants of diabetic mothers. Diabetes Care. , 8 (4): 333-6.
Tilghman J: Obesity and diabetes in African American women. ABNF J. , 14 (3): 66-8.
Will JC, Casper M: The contribution of diabetes to early deaths from ischemic heart disease: US gender and racial comparisons. Am J Public Health. 1996, 86 (4): 576-9.
Shigeta Y, Kikkawa R, Kobayashi N, Katabami J: A community study of diabetes in a population with a high diabetes mortality rate. Tohoku J Exp Med. 1983, 141 Suppl (): 257-60.
Danion F, Letscher-Bru V, Guitard J, Sitbon K, Dellière S, Angoulvant A, Desoubeaux G, Botterel F, Bellanger AP, Gargala G, Uhel F, Bougnoux ME, Gerber V, Michel J, Cornu M, Bretagne S, Lanternier F: Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication. Open Forum Infect Dis. 2022, 9 (2): ofab566.
Mas'uliyatdan voz kechish: tibbiy
Ushbu veb-sayt faqat ta'lim va axborot maqsadlari uchun mo'ljallangan bo'lib, tibbiy maslahat yoki professional xizmatlar ko'rsatmaydi.
Ma'lumotlardan sog'liqni saqlash muammolari yoki kasalliklarni tashxislash yoki davolash uchun foydalanmaslik kerak va shaxsiy tibbiy maslahat so'raganlar litsenziyaga ega bo'lgan shifokor bilan maslahatlashishlari kerak.
Iltimos, savollarga javoblarni ishlab chiqaradigan neyron tarmog'i, ayniqsa, raqamli tarkibga kelganda noto'g'ri ekanligiga e'tibor bering. Masalan, ma'lum bir kasallik bilan kasallangan odamlar soni.
Har doim shifokoringiz yoki boshqa malakali sog'liqni saqlash provayderining maslahatini so'rang. Hech qachon professional tibbiy maslahatni e'tiborsiz qoldirmang yoki ushbu veb-saytda o'qiganingiz sababli uni so'rashni kechiktirmang. Agar siz tibbiy favqulodda vaziyatga duchor bo'lishingiz mumkin deb o'ylasangiz, darhol 911 ga qo'ng'iroq qiling yoki eng yaqin favqulodda vaziyatlar bo'limiga boring. Ushbu veb-sayt yoki uning ishlatilishi bilan hech qanday shifokor- bemor munosabatlari yaratilmaydi. BioMedLib ham, uning xodimlari ham, ushbu veb-saytga hech qanday hissa qo'shuvchi, bu erda taqdim etilgan ma'lumot yoki uning ishlatilishi bilan bog'liq hech qanday bayonot bermaydi.
Mas'uliyatdan voz kechish: mualliflik huquqi
1998-yilgi raqamli ming yillik mualliflik huquqi to'g'risidagi qonun, 17 U.S.C. 512-moddasi (DMCA) Internetda paydo bo'lgan materiallar AQSh mualliflik huquqi to'g'risidagi qonun bo'yicha o'z huquqlarini buzadi deb hisoblaydigan mualliflik huquqi egalari uchun choralar ko'rsatadi.
Agar siz bizning veb-saytimiz yoki xizmatlarimiz bilan bog'liq bo'lgan har qanday tarkib yoki material sizning mualliflik huquqingizni buzadi deb yaxshi ishonchga ega bo'lsangiz, siz (yoki sizning vakilingiz) bizga tarkib yoki materialni olib tashlashni yoki unga kirishni to'xtatishni so'rab xabar yuborishingiz mumkin.
Xabarlar yozma ravishda elektron pochta orqali yuborilishi kerak (elektron pochta manzili uchun "Muloqot" bo'limiga qarang).
DMCA sizning da'vo qilingan mualliflik huquqi buzilganligi to'g'risidagi xabarnomangizda quyidagi ma'lumotlarni o'z ichiga olishini talab qiladi: (1) da'vo qilingan mualliflik huquqi buzilgan asarning tavsifi; (2) da'vo qilingan mualliflik huquqi buzilgan tarkibning tavsifi va bizga tarkibni topishga imkon beradigan etarli ma'lumotlar; (3) siz uchun aloqa ma'lumotlari, shu jumladan sizning manzilingiz, telefon raqami va elektron pochta manzili; (4) siz tomonidan da'vo qilingan tarzda tarkib mualliflik huquqi egasi yoki uning vakili yoki har qanday qonun tomonidan ruxsat berilmaganligiga ishonchingiz borligi to'g'risidagi bayonot;
(5) siz tomonidan yolg'on guvohlik berish jazosi ostida imzolangan, bildirishnomadagi ma'lumotlar to'g'ri ekanligi va siz buzilgan deb da'vo qilingan mualliflik huquqlarini amalga oshirish vakolatiga ega ekanligingiz to'g'risidagi bayonot;
va (6) mualliflik huquqi egasining yoki mualliflik huquqi egasi nomidan harakat qilishga vakolatli shaxsning jismoniy yoki elektron imzosi.
Yuqoridagi barcha ma'lumotlarni kiritmaslik sizning shikoyatingizni ko'rib chiqishni kechiktirishi mumkin.
Aloqa qilish
Iltimos, har qanday savol / taklif bilan bizga elektron pochta xabarini yuboring.
How deadly is diabetes?
Diabetes is a serious and potentially deadly disease.
According to the World Health Organization (WHO), diabetes is the direct cause of over 1.5 million deaths per year, and it is a major risk factor for other diseases such as cardiovascular disease, stroke, and kidney failure.
In 2019, diabetes was the ninth leading cause of death globally, with an estimated 1.5 million deaths directly attributed to the disease.
However, the number of deaths attributable to diabetes is likely much higher, as it is often underreported as a cause of death.
In addition to the direct effects of diabetes, the disease can also lead to various complications that can be life-threatening.
These complications include heart disease, stroke, kidney failure, nerve damage, and vision loss.
People with diabetes are also at a higher risk of developing infections and experiencing slower wound healing, which can lead to severe complications and even death.
It is important to note that with proper management and treatment, the risks associated with diabetes can be significantly reduced.
This includes maintaining good blood sugar control, regular check-ups, and managing other risk factors such as high blood pressure and cholesterol levels.
By managing diabetes effectively, individuals can reduce their risk of developing complications and improve their overall health outcomes.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Taxminan
BioMedLib savol-javob juftliklarini yaratish uchun avtomatlashtirilgan kompyuterlardan (mashinani o'rganish algoritmlaridan) foydalanadi.
Biz PubMed/Medline-ning 35 million biomedikal nashrlaridan boshlaymiz. Shuningdek, RefinedWeb-ning veb-sahifalari.
"Referensiyalar"ga shuningdek "Hujjatdan voz kechish"ga qarang.
